Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kyla M Hagen"'
Autor:
Amy R Dwyer, Carlos Perez Kerkvliet, Thu H Truong, Kyla M Hagen, Raisa I Krutilina, Deanna N Parke, Robert H Oakley, Christopher Liddle, John A Cidlowski, Tiffany N Seagroves, Carol A Lange
Publikováno v:
Endocrinology.
Corticosteroids act on the glucocorticoid receptor (GR; NR3C1) to resolve inflammation and are routinely prescribed to breast cancer patients undergoing chemotherapy treatment to alleviate side effects. Triple negative breast cancers (TNBCs) account
Autor:
Julie H. Ostrander, Carol A. Lange, Kathryn L. Schwertfeger, Nicholas J. Brady, Brian J. Girard, Kyla M. Hagen, Nuri A. Temiz, Hsiangyu Hu, Thu H. Truong
Supplementary Western Blots and RNA expression for PELP1, Western blot controls for fractionation, Kaplan Meier plots, soft agar assay images, and ALDH flow cytometry plots.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03353a0344a5795c36d02217014fdb00
https://doi.org/10.1158/1541-7786.22512645
https://doi.org/10.1158/1541-7786.22512645
Autor:
Julie H. Ostrander, Carol A. Lange, Kathryn L. Schwertfeger, Nicholas J. Brady, Brian J. Girard, Kyla M. Hagen, Nuri A. Temiz, Hsiangyu Hu, Thu H. Truong
Supplementary Tables 1-5 containing gene lists and pathway analyses from Mass spectrometry and RNA-seq.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793b0b79178d6470d91f9c94a65dd322
https://doi.org/10.1158/1541-7786.22512642
https://doi.org/10.1158/1541-7786.22512642
Autor:
Julie H. Ostrander, Carol A. Lange, Kathryn L. Schwertfeger, Nicholas J. Brady, Brian J. Girard, Kyla M. Hagen, Nuri A. Temiz, Hsiangyu Hu, Thu H. Truong
Proline, glutamic acid, leucine-rich protein 1 (PELP1) is overexpressed in approximately 80% of invasive breast tumors. PELP1 dynamically shuttles between the nucleus and cytoplasm, but is primarily nuclear in normal breast tissue. However, altered l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1676b71b17f07460147806608e113b0
https://doi.org/10.1158/1541-7786.c.6540303.v1
https://doi.org/10.1158/1541-7786.c.6540303.v1
Autor:
Elizabeth Benner, Emilio Cortes-Sanchez, Carol A. Lange, Carlos Perez Kerkvliet, Camila O. dos Santos, Thomas Pengo, Chieh Hsiang Yang, Katrin P. Guillen, Sucheta Telang, Thu H. Truong, Ying Wang, Nuri A. Temiz, Marygrace C. Trousdell, Bryan E. Welm, Kyla M. Hagen, Julie H. Ostrander
Publikováno v:
Oncogene
Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades.
Publikováno v:
Endocrinology. 160:430-446
Progesterone receptors (PRs) are key modifiers of estrogen receptor (ER) target genes and drivers of luminal breast cancer progression. Total PR expression, rather than isoform-specific PR expression, is measured in breast tumors as an indicator of f
Autor:
Carol A. Lange, Katrin P. Guillen, Emilio Cortes-Sanchez, Thu H. Truong, Ying Wang, Thomas Pengo, Sucheta Telang, Elizabeth Benner, Bryan E. Welm, Carlos Perez Kerkvliet, Kyla M. Hagen, Julie H. Ostrander, Chieh-Hsiang Yang, Nuri A. Temiz
Publikováno v:
Journal of the Endocrine Society
Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades.
Autor:
Ying Wang, Carlos Perez Kerkvliet, Thomas Pengo, Katrin P. Guillen, Julie H. Ostrander, Nuri A. Temiz, Thu H. Truong, Carol A. Lange, Bryan W. Welm, Kyla M. Hagen, Sucheta Telang, Elizabeth Benner
Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1583b4ba861ae8aa0c88f221bd1d8dc5
https://doi.org/10.1101/2020.08.07.238550
https://doi.org/10.1101/2020.08.07.238550
Autor:
Bryan E. Welm, Katrin P. Guillen, Sucheta Telang, Thomas Pengo, Thu H. Truong, Nuri A. Temiz, Carol A. Lange, Elizabeth Benner, Emilio Cortes-Sanchez, Kyla M. Hagen, Ying Wang, Julie H. Ostrander, Chieh-Hsiang Yang, Carlos Perez Kerkvliet
Publikováno v:
Cancer Research. 81:3085-3085
Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades.
Autor:
Julie H. Ostrander, Carol A. Lange, Nicholas J. Brady, Brian J. Girard, Hsiangyu Hu, Kyla M. Hagen, Thu H. Truong, Kathryn L. Schwertfeger, Nuri A. Temiz
Proline, glutamic acid, leucine-rich protein 1 (PELP1) is overexpressed in approximately 80% of invasive breast tumors. PELP1 dynamically shuttles between the nucleus and cytoplasm, but is primarily nuclear in normal breast tissue. However, altered l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f182e598a362c89d00a23378889b366
https://europepmc.org/articles/PMC5882512/
https://europepmc.org/articles/PMC5882512/